Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C

AIDS

Volumn 21, Issue 16, 2007, Pages 2171-2175

  Raffa, Giuseppina ^a   Maimone, Sergio ^a   Cargnel, Antonietta ^b   Santantonio, Teresa ^c   Antonucci, Giorgio ^d   Massari, Marco ^e   Schiavini, Monica ^b   Caccamo, Gaia ^a   Pollicino, Teresa ^a   Raimondo, Giovanni ^a,f  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f UNIVERSITY OF MESSINA   (Italy)

Author keywords

Chronic hepatitis; Liver DNA analysis; Occult HBV genotype; Occult HBV infection; Viral hepatitis co infection

Indexed keywords

LIVER EXTRACT; VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DNA DETERMINATION; DNA EXTRACTION; FEMALE; GENOME ANALYSIS; GENOTYPE; GOLD STANDARD; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOHISTOCHEMISTRY; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEEDLE BIOPSY; OCCULT HEPATITIS B VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS DETECTION; VIRUS GENOME; VIRUS TYPING;

ADULT; DNA, VIRAL; FEMALE; GENOME, VIRAL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER; MALE; PREVALENCE; RETROSPECTIVE STUDIES; VIRUS LATENCY;

EID: 37349079496     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282eea504     Document Type: Article

References (46)

1. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000; 31:488-495.
2. Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 2005; 42:302-308.
3. Bock CT, Schwinn S, Locarnini S, Fyfe J, Manns MP, Trautwein C, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol 2001; 307:183-196.
4. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. New Engl J Med 2004; 350:1118-1129.
5. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely 'occult'? Hepatology 2001; 34:194-203.
6. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2:479-486.
7. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9:243-257.
8. Raimondo G, Pollicino T, Squadrito G. What is the clinical impact of occult hepatitis B virus infection? Lancet 2005; 365:638-640.
9. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol 2005; 34:S15-S21.
10. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46:160-170.
11. Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, et al. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol 1997; 51:313-318.
12. De Maria N, Colantoni A, Friedlander L, Leandro G, Idilman R, Harig J, et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 2000; 95:3529-3536.
13. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Stanzione M, Filippini P, et al. Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment. J Med Virol 2001; 65:681-687.
14. Jilg W, Sieger E, Zachoval R, Schatzl H. Individuals with antibodies against hepatitis B core antigens as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995; 23: 15-20.
15. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol 1998; 54:249-255.
16. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341:22-26.
17. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999; 58:201-207.
18. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and 'silent' HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol 2001; 64:350-355.
19. Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002; 123:1084-1089.
20. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Crax A, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126:102-110.
21. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127:S56-S61.
22. Squadrito G, Pollicino T, Cacciola I, Caccamo G, Villari D, La Masa T, et al. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 2006; 106:1326-1330.
23. Donato F, Gelatti U, Limina RM, Fattovich G. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 2006; 25:3756-3770.
24. Nunez M, Rios P, Perez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. Aids 2002; 16:2099-2101.
25. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998; 17:6-13.
26. Torres-Baranda R, Bastidas-Ramirez BE, Maldonado-Gonzalez M, Sanchez-Orozco LV, Vazquez-Vals E, Rodriguez-Noriega E, et al. Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction. Ann Hepatol 2006; 5:34-40.
27. Filippini P, Coppola N, Pisapia R, Scolastico C, Marrocco C, Zaccariello A, et al. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. Aids 2006; 20:1253-1260.
28. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006; 35:14-20.
29. Pogany K, Zaaijer HL, Prins JM, Wit FW, Lange JM, Beld MG. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients. AIDS Res Hum Retroviruses 2005; 21:922-926.
30. Neau D, Winnock M, Jouvencel AC, Faure M, Castera L, Legrand E, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005; 40:750-753.
31. Santos EA, Yoshida CF, Rolla VC, Mendes JM, Vieira IF, Arabe J, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003; 22:92-98.
32. Wagner AA, Denis F, Weinbreck P, Loustaud V, Autofage F, Rogez S, et al. Serological pattern 'antihepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants. AIDS 2004; 18:569-571.
33. Goncales FL Jr, Pereira JS, Da Silva C, Thomaz GR, Pavan MH, Fais VC, et al. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus. Clin Diagn Lab Immunol 2003; 10: 718-720.
34. Piroth L, Grappin M, Buisson M, Duong M, Portier H, Chavanet P. Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 23:356-357.
35. Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006; 44:S65-S70.
36. Shi S-R, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA extraction from archival formalin.fixed, paraffin-embedded tissue sections based on the antigen retrival principal: heating under the influence of pH. J Histochem Citochem 2002; 50:1005-1011.
37. Jung K, Ha Y, Kim S-H, Chae C. Development of polymerase chain reaction and comparison with in situ hybridisation for the detection of haemophilus parasuis in formalin-fixed, paraffin-embedded tissues. J Vet Med Sci 2004; 66: 841-845.
38. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45:277-285.
39. Vento S, Di Perri G, Luzzati R, Cruciani M, Garofano T, Mengoli C, et al. Clinical reactivation of hepatitis B in anti-HBs positive patients with AIDS. Lancet 1989; I:123-126.
40. Altfeld M, Rockstroh JK, Addo M, Kupfer B, Pult I, Will H, et al. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol 1998; 29:306-309.
41. Manegold C, Hannoun C, Wywiol A, Dietrich M, Poliwka S, Chiwakata CB, et al. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy. Clin Inf Dis 2001; 32: 144-148.
42. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol 2005; 42:S28-S34.
43. Koibuchi T, Hitani A, Nakamura T, Nojiri N, Nakajima K, Jyuji T, et al. Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan. J Med Virol 2001; 64:435-440.
44. Perez-Olmeda M, Nunez M, Garcia-Samaniego J, Rios P, Gonzalez-Lahoz J, Soriano V. Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications. AIDS Res Hum Retroviruses 2003; 19:657-659.
45. Zehender G, De Maddalena C, Milazzo L, Piazza M, Galli M, Tanzi E, et al. Hepatitis B virus genotype distribution in HIV-1 coinfected patients. Gastroenterology 2003; 125: 1559-1560.
46. Ramos B, Nunez M, Martin-Carbonero M, Sheldon J, Rios P, Labarga P. Hepatitis B virus genotypes and lamivudine resistance mutations in Hiv/hepatitis B virus-coinfected patients. J Acquir Immune Defic Syndr 2007; In press.